EU life sciences regulatory reform featuring biotechnology, pharmaceutical legislation, health data, health technology assessment and AI governance.

By:
On:
In: Life Sciences & Healthcare

Europe is reworking the rules governing biotechnology, pharmaceuticals, clinical evidence, health data and artificial intelligence. For life sciences companies, the challenge is no longer just regulatory compliance. It is understanding how these interconnected frameworks will influence innovation, investment, manufacturing and patient access. Europe is entering a consequential period of changeContinue Reading